- March 14, 2017 | BY
It’s been 11 years since the EU passed legislation requiring companies to register their use of chemicals by 2018. How’s that going? Day Two of our SOT coverage.
- March 13, 2017 | BY
Molecular imaging has long been a major player in clinical medicine. What about its utility in earlier phases of preclinical drug development?
- March 10, 2017 | BY
Is CRISPR legit, Congress makes a significant move and the FDA tries to decide what makes healthy food “healthy.”
- March 8, 2017 | BY
A period list of methods, tools and people driving research and development. Our scientists present nine tools helping to advance safety assessment. (The list is not ranked.)
- March 6, 2017 | BY
Faced with a difficult prognosis, registerd nurse Carla Jenkins looks to research for a reprieve in her battle with cancer. Firsti in our Eureka Moments series.
- March 3, 2017 | BY
The WHO introduces the dirty dozen, colon cancer on the rise in young Americans, and bringing back cryopreserved organs.
- March 2, 2017 | BY
Where is the microbiome-based therapeutics market headed? A Charles River Think Tank explores the possibilities for changing how we treat disease.
- March 1, 2017 | BY
No one can really claim whether tau or amyloid beta commands the bigger role because the proteins are so linked.
- February 24, 2017 | BY
Are butterflies in the stomach a real thing, discovering the fountain of youth, the importance of knowing your cancer genome.
- February 23, 2017 | BY
How innate immune cells are turning on those killer T cells to attack cancer. Day Two of the Molecular Medicine Tri-C meeting.